IP Library Granted Patent US 8,445,725
Granted Patent B2
US 8,445,725 · App. 12/811,833 · Granted May 21, 2013

Process for the preparation of iosimenol

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,445,725
App. No.
12/811,833
Granted
May 21, 2013
Kind
B2
Abstract

A process for the preparation of iosimenol comprising reacting 5,5′-[(1,3-dioxo-1,3-propanediyl)diimino]bis[N-(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide] (C-VI) with a 3-halo-1,2-propanediol in an aqueous solvent. A process for the preparation of C-VI comprising reacting 3,3′-[(1,3-dioxo-1,3-propanediyl)diimino]bis[5-(aminocarbonyl)-2,4,6-triiodobenzoyl chloride] (C-V) with 3-amino-1,2-propanediol in the presence of an inorganic base and a suitable non-aqueous polar solvent. A process for the preparation of C-V comprising reacting 3-amino-5-(aminocarbonyl)-2,4,6-triiodobenzoyl chloride (C-IV) with malonyl dichloride in a solvent comprising a suitable ester solvent, a suitable nitrile solvent or mixtures thereof.

Claims (23)

1. A process for the preparation of iosimenol, the process comprising reacting 5,5′-[(1,3-dioxo-1,3-propanediyl)diimino]bis[N-(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide], C-VI, with a 3-halo-1,2-propanediol in an aqueous solvent, in the presence of suitable base and a suitable additive, wherein C-VI has the formula:

2. The process of claim 1 wherein the 3-halo-1,2-propanediol is 3-chloro-1,2-propanediol.

3. The process of claim 1 wherein the additive is selected from an alkali metal or alkaline earth metal salt of a halide or C 1 -C 6 carboxylic acid, or combinations thereof; wherein halide is selected from chloride, bromide or iodide.

4. The process of claim 3 wherein the additive is selected from lithium chloride, sodium chloride, potassium chloride, cesium chloride, magnesium chloride, calcium chloride, strontium chloride, barium chloride, or the equivalent bromide, iodide or acetate, or combinations thereof.

5. The process of claim 4 wherein the additive is calcium chloride.

6. The process of claim 1 wherein the aqueous solvent is water.

7. The process of claim 6 wherein the base is sodium hydroxide.

8. The process of claim 1 wherein the process further comprises the preparation of 5,5′-[(1,3-dioxo-1,3-propanediyl)diimino]bis[N-(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide], (C-VI), by reacting 3,3′-[(1,3-dioxo-1,3-propanediyl)diimino]bis[5-(aminocarbonyl)-2,4,6-triiodobenzoyl chloride] (C-V) with 3-amino-1,2-propanediol in the presence of a base wherein C-V has the formula:

9. The process of claim 8 wherein the reaction is carried out in a non-aqueous polar solvent selected from dimethylsulfoxide or amide solvents.

10. The process of claim 8 wherein the base is lithium hydroxide, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, lithium carbonate, triethylamine or diisopropylethylamine, tetramethylammonium hydroxide, tetraethylammonium hydroxide, or a combination thereof.

11. The process of claim 9 wherein the solvent is N,N-dimethylacetamide and the base is sodium hydroxide.

12. The process of claim 8 wherein the process further comprises the preparation of C-V by treating 3-amino-5-(aminocarbonyl)-2,4,6-triiodobenzoyl chloride (C-IV) with malonyl dichloride.

13. The process of claim 12 wherein the process further comprises the preparation of 3-amino-5-(aminocarbonyl)-2,4,6-triiodobenzoyl chloride (C-IV) by treating 3-amino-5-(aminocarbonyl)-2,4,6-triiodobenzoic acid (C-III) with a chlorinating reagent in the presence of a catalyst wherein C-III has the formula:

14. The process of claim 13 wherein the chlorinating reagent is thionyl chloride.

15. The process of claim 13 wherein the catalyst is an amide or amine catalyst.

16. The process of claim 15 wherein the catalyst is tetramethylurea, N,N-dimethylformamide, N,N-dimethylacetamide, N-methylmorpholine, N-methylpyrrolidone, 4-dimethylaminopyridine, or a combination thereof.

17. A process for the preparation of 5,5′-[(1,3-dioxo-1,3-propanediyl)diimino]bis[N-(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide], (C-VI), by reacting 3,3′-[(1,3-dioxo-1,3-propanediyl)diimino]bis[5-(aminocarbonyl)-2,4,6-triiodobenzoyl chloride] (C-V) with 3-amino-1,2-propanediol in the presence of an inorganic base selected from alkali metal hydroxides, alkali metal carbonates, or combinations thereof and a suitable non-aqueous polar solvent wherein 3,3′-[(1,3-dioxo-1,3-propanediyl)diimino]bis[5-(aminocarbonyl)-2,4,6-triiodobenzoyl chloride] (C-V) has the formula:

18. The process of claim 17 wherein the solvent comprises a non-aqueous polar solvent selected from dimethylsulfoxide or amide solvents.

19. The process of claim 17 wherein the base is lithium hydroxide, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, lithium carbonate, or a combination thereof.

20. The process of claim 18 wherein the solvent is N,N-dimethylacetamide and the base is sodium hydroxide.

21. The process of claim 17 further comprising:

concentrating the C-VI reaction mixture to remove a portion of the non-aqueous polar solvent, and

contacting the concentrated reaction mixture with a non-solubilizing solvent selected from water, 10% to 15% NaCl solution, acetone, alcohols, or combinations thereof.

Assignments (6)
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 032480, FRAME 0001 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0322 →
RELEASE OF SECURITY INTEREST Recorded Nov 30, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 037172/0094 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2014
From: MALLINCKRODT LLC
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 034715/0531 →
SECURITY INTEREST Recorded Mar 19, 2014
From: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS INC.; MALLINCKRODT CARIBBEAN, INC.; MALLINCKRODT US POOL LLC; MALLINCKRODT INC.; LUDLOW CORPORATION; CNS THERAPEUTICS, INC.; ENTERPRISES HOLDINGS, INC.; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS, INC; MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC; MALLINCKRODT ENTERPRISES HOLDINGS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 032480/0001 →
CHANGE OF LEGAL ENTITY Recorded Aug 16, 2011
From: MALLINCKRODT INC.
To: MALLINCKRODT LLC
Reel/Frame 026754/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 7, 2010
From: BAILEY, ALLAN R.; JONES, MICHELLE M.; KNELLER, MILLS T.; PETROV, ALEXANDER N.; WHITE, DAVID H.; EGAN, OLIVER; ROONEY, FIONA
To: MALLINCKRODT INC.
Reel/Frame 024642/0067 →